Cargando…
Reporting guidelines for burden of disease studies: why and how?
BACKGROUND: The Disability Adjusted Life Year (DALY) is a frequently used metric to assess burden of disease (BoD). Many independent BoD studies have been performed across Europe, showing wide variations and inconsistencies in the application and reporting of DALY specific methods. The European Burd...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593658/ http://dx.doi.org/10.1093/eurpub/ckac130.097 |
_version_ | 1784815216770416640 |
---|---|
author | Devleesschauwer, B Haagsma, JA Charalampous, P Assunção, R Bari, C Di Gorasso, V Grant, I Hilderink, H Idavain, J Lesnik, T Majdan, M Santric-Milicevic, M Pallari, E Pires, SM Plass, D Wyper, GMA Von der Lippe, E |
author_facet | Devleesschauwer, B Haagsma, JA Charalampous, P Assunção, R Bari, C Di Gorasso, V Grant, I Hilderink, H Idavain, J Lesnik, T Majdan, M Santric-Milicevic, M Pallari, E Pires, SM Plass, D Wyper, GMA Von der Lippe, E |
author_sort | Devleesschauwer, B |
collection | PubMed |
description | BACKGROUND: The Disability Adjusted Life Year (DALY) is a frequently used metric to assess burden of disease (BoD). Many independent BoD studies have been performed across Europe, showing wide variations and inconsistencies in the application and reporting of DALY specific methods. The European Burden of Disease Network (burden-eu) aims to develop guidelines for reporting DALY calculation studies which may enhance transparency and comparability of BoD estimates across Europe and beyond. METHODS: A burden-eu working group of experts generated a list of potential reporting items based on existing literature, guidance for developing guidelines and consultations with BoD experts. To pilot the drafted product, we asked BoD experts and non-experts to apply it to existing BoD studies. We received feedback and we revised the guidelines accordingly. RESULTS: The guide for DALY calculation studies comprises about 25 items that should be reported in BoD studies. We included information about the study setting, data input sources including methods for data corrections, DALY-specific methods (e.g., YLL life table, YLD approach, disability weights etc), data analyses, and data limitations. We also included information on how users can compare their new estimates with previously available BoD estimates. CONCLUSIONS: We introduced a reporting instrument for DALY calculations that can be used to document input data and methodological design choices in BoD studies. The application of such guidelines will enhance usability of BoD estimates for decision-makers as well as global, regional, and national health experts. KEY MESSAGES: Application of reporting guidelines will increase consistency and transparency in reporting of BoD studies, thus enhancing usability of BoD estimates. Reporting guidelines for BoD studies will serve as an educational tool for better understanding the complexity of DALY methodological design approaches. |
format | Online Article Text |
id | pubmed-9593658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95936582022-11-22 Reporting guidelines for burden of disease studies: why and how? Devleesschauwer, B Haagsma, JA Charalampous, P Assunção, R Bari, C Di Gorasso, V Grant, I Hilderink, H Idavain, J Lesnik, T Majdan, M Santric-Milicevic, M Pallari, E Pires, SM Plass, D Wyper, GMA Von der Lippe, E Eur J Public Health Poster Walks BACKGROUND: The Disability Adjusted Life Year (DALY) is a frequently used metric to assess burden of disease (BoD). Many independent BoD studies have been performed across Europe, showing wide variations and inconsistencies in the application and reporting of DALY specific methods. The European Burden of Disease Network (burden-eu) aims to develop guidelines for reporting DALY calculation studies which may enhance transparency and comparability of BoD estimates across Europe and beyond. METHODS: A burden-eu working group of experts generated a list of potential reporting items based on existing literature, guidance for developing guidelines and consultations with BoD experts. To pilot the drafted product, we asked BoD experts and non-experts to apply it to existing BoD studies. We received feedback and we revised the guidelines accordingly. RESULTS: The guide for DALY calculation studies comprises about 25 items that should be reported in BoD studies. We included information about the study setting, data input sources including methods for data corrections, DALY-specific methods (e.g., YLL life table, YLD approach, disability weights etc), data analyses, and data limitations. We also included information on how users can compare their new estimates with previously available BoD estimates. CONCLUSIONS: We introduced a reporting instrument for DALY calculations that can be used to document input data and methodological design choices in BoD studies. The application of such guidelines will enhance usability of BoD estimates for decision-makers as well as global, regional, and national health experts. KEY MESSAGES: Application of reporting guidelines will increase consistency and transparency in reporting of BoD studies, thus enhancing usability of BoD estimates. Reporting guidelines for BoD studies will serve as an educational tool for better understanding the complexity of DALY methodological design approaches. Oxford University Press 2022-10-25 /pmc/articles/PMC9593658/ http://dx.doi.org/10.1093/eurpub/ckac130.097 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Walks Devleesschauwer, B Haagsma, JA Charalampous, P Assunção, R Bari, C Di Gorasso, V Grant, I Hilderink, H Idavain, J Lesnik, T Majdan, M Santric-Milicevic, M Pallari, E Pires, SM Plass, D Wyper, GMA Von der Lippe, E Reporting guidelines for burden of disease studies: why and how? |
title | Reporting guidelines for burden of disease studies: why and how? |
title_full | Reporting guidelines for burden of disease studies: why and how? |
title_fullStr | Reporting guidelines for burden of disease studies: why and how? |
title_full_unstemmed | Reporting guidelines for burden of disease studies: why and how? |
title_short | Reporting guidelines for burden of disease studies: why and how? |
title_sort | reporting guidelines for burden of disease studies: why and how? |
topic | Poster Walks |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593658/ http://dx.doi.org/10.1093/eurpub/ckac130.097 |
work_keys_str_mv | AT devleesschauwerb reportingguidelinesforburdenofdiseasestudieswhyandhow AT haagsmaja reportingguidelinesforburdenofdiseasestudieswhyandhow AT charalampousp reportingguidelinesforburdenofdiseasestudieswhyandhow AT assuncaor reportingguidelinesforburdenofdiseasestudieswhyandhow AT baricdi reportingguidelinesforburdenofdiseasestudieswhyandhow AT gorassov reportingguidelinesforburdenofdiseasestudieswhyandhow AT granti reportingguidelinesforburdenofdiseasestudieswhyandhow AT hilderinkh reportingguidelinesforburdenofdiseasestudieswhyandhow AT idavainj reportingguidelinesforburdenofdiseasestudieswhyandhow AT lesnikt reportingguidelinesforburdenofdiseasestudieswhyandhow AT majdanm reportingguidelinesforburdenofdiseasestudieswhyandhow AT santricmilicevicm reportingguidelinesforburdenofdiseasestudieswhyandhow AT pallarie reportingguidelinesforburdenofdiseasestudieswhyandhow AT piressm reportingguidelinesforburdenofdiseasestudieswhyandhow AT plassd reportingguidelinesforburdenofdiseasestudieswhyandhow AT wypergma reportingguidelinesforburdenofdiseasestudieswhyandhow AT vonderlippee reportingguidelinesforburdenofdiseasestudieswhyandhow |